Effects of cisplatin on mitochondrial function in Jurkat cells

Chemical Research in Toxicology

Volumn 17, Issue 8, 2004, Pages 1102-1111

  Tacka, Kirk A ^a   Dabrowiak, James C ^a   Goodisman, Jerry ^a   Penefsky, Harvey S ^b   Souid, Abdul Kader ^c  

^a SYRACUSE UNIVERSITY   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CISPLATIN; DNA FRAGMENT; PALLADIUM; PEPTIDE DERIVATIVE; PLATINUM; PORPHYRIN;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BEEF CATTLE; CELL RESPIRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG EFFECT; DRUG EXPOSURE; HEART MITOCHONDRION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; OXYGEN CONSUMPTION; QUANTITATIVE ANALYSIS; RESPIRATORY CHAIN;

AMINO ACID CHLOROMETHYL KETONES; CELL COUNT; CELL RESPIRATION; CELL SURVIVAL; CISPLATIN; DNA ADDUCTS; DNA FRAGMENTATION; HUMANS; JURKAT CELLS; MITOCHONDRIA; OXYGEN CONSUMPTION;

BOS TAURUS;

EID: 4243082130     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0499564     Document Type: Article

References (59)

1. Hatefi, Y. (1985) The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem. 54, 1015-1069.
2. Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature 407, 770-776.
3. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
4. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K.-M., Krammer, P. H., and Peter, M. E. (1998) Two CD95 (APO-1/fas) signaling pathways. EMBO J. 17, 1675-1687.
5. Lemasters, J. J., Qian, T., Bradham, C. A., Brenner, D. A., Cascio, W. E., Trost, L. C., Nishimura, Y., Nieminen, A. L., and Herman, B. (1999) Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J. Bioenerg. Biomembr. 31, 305-319.
6. Petit, P. X., Zamzami, N., Vayssiere, J. L., Mignotte, B., Kroemer, G., and Castedo, M. (1997) Implication of mitochondria in apoptosis. Mol. Cell. Biochem. 174, 185-188.
7. Szewczyk, A., and Wojtczak, L. (2002) Mitochondria as a pharmacological target. Pharmacol. Rev. 54, 101-127.
8. Souid, A.-K., Dubowy, R. L., Blaney, S. M., Hershon, L., Sullivan, J., McLeod, W. D., and Bernstein, M. L. (2003) Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors: Children's Oncology Group trial 9970. Clin. Cancer Res. 9, 703-710.
9. Hagrman, D., Goodisman, J., Dabrowiak, J. C., and Souid, A.-K. (2003) Kinetic study on the reaction of cisplatin with metallothionein. Drug Metab. Dispos. 31, 916-923.
10. Dabrowiak, J. C., Goodisman, J., and Souid, A.-K. (2002) Kinetic study of the reaction of cisplatin with thiols. Drug Metab. Dispos. 30, 1378-1384.
11. Sadowitz, P. D., Hubbard, B. A., Dabrowiak, J. C., Goodisman, J., Tacka, K. A., Atkas, M. K., Cunningham, M. J., Dubowy, R. L., and Souid, A.-K. (2002) Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. Drug Metab. Dispos. 30, 183-190.
12. Gately, D. P., and Howell, S. B. (1993) Cellular accumulation of the anticancer agent cisplatin: A review. Br. J. Cancer 67, 1171-1176.
13. Katano, K., Kondo, A., Safaei, R., Holzer, A., Samimi, G., Mishima, M., Kuo, Y.-M., Rochdi, M., and Howell, S. B. (2002) Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res. 62, 6559-6565.
14. Katano, K, Safaei, R., Samimi, G., Holzer, A., Rochdi, M., and Howell, S. B. (2003) The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol. Pharmacol. 64, 466-473.
15. Eastman, A. (1999) The mechanism of action of apoptosis cisplatin: From adducts to apoptosis. In Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B., Ed.) pp 111-134, Weinheim, Wiley-VCH, Zurich.
16. Zamble, D. B., and Lippard, S. J. (1999) The response of cellular proteins to cisplatin-damaged DNA. In Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (Lippert, B., Ed.) pp 73-110, Weinheim, Wiley-VCH, Zurich.
17. Gonzalez, V. M., Fuertes, M. A., Alonso, C., and Ferez, J. M. (2001) Is cisplatin-induced cell death always produced by apoptosis? Mol. Pharmacol. 59, 657-663.
18. Meyer, K. B., and Madias, N. E. (1994) Cisplatin nephrotoxicity. Miner. Electrolyte Metab. 20, 201-213.
19. Brady, H. R., Kone, B. C., Stromski, M. E., Zeidel, M. L., Giebisch, G., and Gullans, S. R. (1990) Mitochondrial injury and early event in cisplatin toxicity to renal proximal cells. Am. J. Physiol. 258, F1181-F1187.
20. Schwerdt, G., Freudinger, R., Schuster, C., Silbernagl, S., and Geke, M. (2003) Inhibition of mitochondria prevents cell death in kidney epithelial cells by intra- and extracellular acidification. Kidney Int. 63, 1725-1735.
21. Lau, A. H. (1999) Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int. 56, 1295-1298.
22. Kruidering, M., Water, B. V. D., Heer, E. D., Mulder, G. J., and Nagelkerrke, J. F. (1997) Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: Mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J. Pharmacol. Exp. Ther. 280, 638-649.
23. Nowak, G. (2002) Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J. Biol. Chem. 45, 43377-43388.
24. Henkels, K. M., and Turchi, J. J. (1999) Cisplatin-induced apoptosis proceeds by caspase-3-dependent and-independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res. 59, 3077-3083.
25. Melendez-Zaigla, J., Cruz, E., Maldonado, V., and Espinoza, A. M. (1999) mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin. Biochem. Mol. Biol. Int. 47, 765-771.
26. Evans, R. M., and Simpkins, H. (1998) Cisplatin induced intermediate filament reorganization and mitochondrial function in 3T3 cells and drug-sensitive and -resistant Walker 256 cells. Exp. Cell Res. 245, 69-78.
27. Liang, B. C., and Ullyatt, E. (1998) Increased sensitivity to cis-diaminedichloroplatinum-induced apoptosis with mitochondrial DNA depletion. Cell Death Differ. 5, 694-701.
28. Murata, T., Hibasami, H., Maekawa, S., Tagawa, T., and Nakashima, K. (1990) Preferential binding of cisplatin to mitochondrial DNA and suppression of ATP generation in human malignant melanoma cells. Biochem. Int. 20, 949-959.
29. Harper, M.-E., Atoniou, A., Villalobos-Menuey, E., Russo, A., Trauger, R., Vendemelio, M., George, A., Bartholomew, R., Carlo, D., Shaikh, A., Kupperman, J., Newell, E. W., Bespalov, I. A., Wallace, S. S., Liu, Y., Rogers, J. R., Gibbs, G. L., Leahy, J. L., Camley, R. E., Melamede, R., and Newell, M. K. (2002) Characterization of a novel metabolic strategy used by drug-resistant tumor cells. FASEB J. 16, 1550-1557.
30. Souid, A.-K., Tacka, K. A., Galvan, K. A., and Penefsky, H. S. (2003) Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem. Pharmacol. 66, 977-987.
31. Miller, S. E., and House, D. A. (1990) The hydrolysis products of cis-dichlorodiammineplatinum (II). Inorg. Chim. Acta 173, 53-60.
32. Allison, D. C., and Ridolpho, P. (1980) Use of a trypan blue assay to measure the deoxyribonucleic acid content and radioactive labeling of viable cells. J. Histochem. Cytochem. 28, 700-703.
33. Beyer, R. E. (1967) Preparation, properties, and conditions for assay of phosphorylating electron transport particles (ETPH) and its variations. Methods Enzymol. 10, 186-194.
34. Blair, P. V. (1967) The large-scale preparation and properties of heart mitochondria from slaughterhouse material. Methods Enzymol. 10, 78-81.
35. Miessler, G. L., and Tarr, D. A. (2004) Inorganic Chemistry, 3rd ed., Pearson Prentice Hall, Upper Saddle River, New Jersey.
36. Slee, E. A., Zhu, H., Chow, S. C., MacFarlane, M., Nicholson, D. W., and Cohen, G. M. (1996) Benzyloxycarbonyl-val-ala-asp (OMe) fluoromethyl ketone (z-VAD.fmk) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315, 21-24.
37. Lo, L.-W., Koch, C. J., and Wilson D. F. (1996) Calibration of oxygen-dependent quenching of the phosphorescence of Pd-mesotetra (4-carboxyphenyl) porphine: A phosphor with general application for measuring oxygen concentration in biological systems. Anal. Biochem. 236, 153-160.
38. Gong, J., Traganos, F., and Darzynkiewicz, Z. (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218, 314-319.
39. Mimnaugh, E. G., Yunmbam, M. K., Li, Q., Bonvini, P., Hwang, S.-G., Trepel, J., Reed, E., and Neckers, L. (2000) Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors. Biochem. Pharmacol. 60, 1343-1354.
40. Zwelling, L. A., Anderson, T., and Kohn, K. W. (1979) DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum (II) diaminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res. 39, 365-369.
41. Knox, R. J., Friedlos, F. F., Lydall, D. A., and Roberts J. J. (1986) Mechanism of cytotoxicty of anticancer drugs: Evidence that cis- diaminedichloroplatinum(II) and cis-diamine-(1,1-cyclobutanedicarboxylato) platinum(II) differ only in the kinetics of their interaction with DNA. Cancer Res. 46, 1972-1979.
42. Johnson, S. W., Swiggard, P. A., Handel, L. M., Brennan, J. M., Godwin, A. K., Ozols, R. F., and Hamilton, T. C. (1994) Relationship between platinum-DNA adduct formation and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Cancer Res. 54, 5911-5916.
43. Woynarowski, J. M., Faivre, S., Herzig, M. C. S., Arnett, B., Chapman, W. G., Trevino, A. V., Raymond, E., Chaney, S. G., Vaisman, A., Varchenko, M., and Juniewicz, P. E. (2000) Oxaliplatin-induced damage of cellular DNA. Mol. Pharmacol. 58, 920-927.
44. Faivre, S., Chan, D., Salinas, R., Woynarowska, B., and Woynarowski, J. M. (2003) DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells. Biochem. Pharmacol. 66, 225-237.
45. Calvert, H., Judson, L, and van der Vijgh, W. J. (1993) Platinum complexes in cancer medicines: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity. Cancer Surv. 17, 189-217.
46. Zheng, H., Fink, D., and Howell, S. B. (1997) Pharmacoligical basis for a novel therapeutic strategy based on the use of aquated cisplatin. Clin. Cancer Res. 3, 1157-1165.
47. Aggarwal, S. K. (1993) A histochemical approach to the mechanism of action of cisplatin and its analogues. J. Histochem. Cytochem. 41, 1053-1073.
48. Cohen, G. M. (1997) Caspases: The executioners of apoptosis. Biochem. J. 326, 1-16.
49. Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., and Gougeon, M.-L. (1995) Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130, 157-167.
50. Springer, L. N., and Stewart, B. W. (1998) N-(4-Hydroxyphenyl)retinamide- induced death in human lymphoblastoid cells: 50 kb DNA breakage as a means of distinguishing apoptosis form necrosis. Cancer Lett. 128, 189-196.
51. Winter, D. B., Gearhart, P. J., and Bohr, V. A. (1998) Homogeneous rate of degradation of nuclear DNA during apoptosis. Nucleic Acids Res. 26, 4422-4425.
52. Koo, M. S., Kwo, Y. G., Park, J. H., Choi, W. J., Billiar, T. R., and Kim, Y. M. (2002) Signaling and function of caspase and c-jun N-terminal kinases in cisplatin-induced apoptosis. Mol. Cells 13, 194-201.
53. Eischen, C. M., Kottke, T. J., Martins, L. M., Basi, G. S., Tung, J. S., Earnshaw, W. C., Leibson, P. J., and Kaufmann, S. H. (1997) Comparison of apoptosis in wild-type and fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on fas/fas ligand interactions. Blood 90, 935-943.
54. Rich, T., Allen, R. L., and Wyllie, A. H. (2000) Defying death after DNA damage. Nature 407, 777-783.
55. Wang, G.-Q., Gastman, B. R., Wieckowski, E., Goldstein, L. A., Gambotto, A., Kim, T.-H., Fang, B., Rabinovitz, A., Yin, X.-M., and Rabinowich, H. (2001) A role for mitochondrial Bak in apoptotic response to anticancer drugs. J. Biol. Chem. 276, 34307-34317.
56. Rudin, C. M., Yang, Z., Schumaker, L. M., VanderWeele, D. J., Newkirk, K., Egorin, M. J., Zuhowski, E. G., and Cullen, K. J. (2003) Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resitance. Cancer Res. 63, 312-318.
57. Ferriera, C. G., Span, S. W., Peters, G. J., Kryut, F. A. E., and Giaccone, G. (2000) Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the nonsmall cell lung cancer cell line NCI-H460. Cancer Res. 60, 7133-7141.
58. Zhou, R., Vander Heiden, M. G., and Rudin, C. M. (2002) Genotoxic exposure is associated with alterations in glucose uptake and metabolism. Cancer Res. 62, 3515-3520.
59. Pelicano, H., Feng, L., Zhou, Y., Carew, J. S., Hileman, E. O., Plunkett, W., Keating, M. J., and Huang, P. (2003) Inhibition of mitochondrial respiration: A novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J. Biol. Chem. 278, 37832-37839.